Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy
- PMID: 38274096
- PMCID: PMC10808646
- DOI: 10.3389/fmolb.2023.1277508
Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy
Abstract
Background: Serine protease inhibitor E (SERPINE) family genes participate in the tumor growth, cancer cell survival and metastasis. However, the SERPINE family members role in the prognosis and their clinical therapeutic potentials in various human cancer types have not been elaborately explored. Methods: We preliminarily analyzed expression levels and prognostic values of SERPINE family genes, and investigated the correlation between SERPINEs expression and tumor microenvironment (TME), Stemness score, clinical characteristic, immune infiltration, tumor mutational burden (TMB), immune subtype, and drug sensitivity in pan-cancer, which based on updated public databases and integrated some bioinformatics analysis methods. In addition, we conducted the enrichment analysis of SERPINEs from DAVID and KOBAS databases. Results: SERPINE1, SERPINE2, and SERPINE3 expression were upregulated in nine cancers, twelve cancers, and six cancers, respectively. The expression of SERPINE family genes was associated with the prognosis in several cancers from The Cancer Genome Atlas (TCGA). Furthermore, SERPINE family genes expression also had a significant relation to stromal and immune scores, and RNA stemness score and DNA stemness score in pan-cancer. SERPINE1 and SERPINE2 expression significantly increased in tumor advanced stage in colon adenocarcinoma (COAD). Results showed that SERPINE1 and SERPINE2 expression were negatively related with B cells and Monocytes, respectively. SERPINE2 expression had a significantly positive relation with B cells and Macrophages. In terms of TMB, SERPINE1, SERPINE2, and SERPINE3 were found to associated with TMB in seven cancers, fourteen cancers, and four cancers, respectively. Moreover, all SERPINE gene family members were significantly correlated with immune subtypes. SERPINE1 expression had a significantly positive or negative correlation with drug sensitivity. Conclusion: The study indicated the great potential of SERPINE family genes as biomarkers for prognosis and provided valuable strategies for further investigation of SERPINE family genes as potential targets in cancer.
Keywords: SERPINE family genes; bioinformatics; immune infiltration; pan-cancer; prognosis; tumor microenvironment.
Copyright © 2024 Liu, Li, Chen, Zhu, Shi, Dang, Zhang and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.J Cell Mol Med. 2024 Aug;28(15):e18579. doi: 10.1111/jcmm.18579. J Cell Mol Med. 2024. PMID: 39086142 Free PMC article.
-
Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.Medicine (Baltimore). 2023 Dec 15;102(50):e36001. doi: 10.1097/MD.0000000000036001. Medicine (Baltimore). 2023. PMID: 38115305 Free PMC article.
-
A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.Life Sci. 2021 May 15;273:119307. doi: 10.1016/j.lfs.2021.119307. Epub 2021 Mar 8. Life Sci. 2021. PMID: 33691171
-
HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.Biomed Res Int. 2022 Feb 23;2022:3924400. doi: 10.1155/2022/3924400. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9789013. doi: 10.1155/2024/9789013 PMID: 35252444 Free PMC article. Retracted.
-
A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2).Front Genet. 2022 Jul 22;13:927046. doi: 10.3389/fgene.2022.927046. eCollection 2022. Front Genet. 2022. PMID: 35937984 Free PMC article. Review.
Cited by
-
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era.Cancers (Basel). 2024 Oct 21;16(20):3553. doi: 10.3390/cancers16203553. Cancers (Basel). 2024. PMID: 39456647 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous